Biomarker for Hereditary AngioEdema Disease

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions
C1 Esterase Inhibitor DeficiencyAngio EdemaC4 DeficiencyHAEHereditary AngioedemaHereditary Angioedema Type IIHereditary Angioedema Type IIIHereditary Angioedema Type I
Trial Locations (7)

1030

Clinica San Pablo de Surco, Lima

54100

Sakarya University Research and Training Hospital, Sakarya

547530

Centrul Clinic Mediquest, Târgu Mureş

682041

Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre, Kerola

0014

Arabkir JMC-ICAH, Yerevan

0159

Center of Allergy and Immunology, Tbilisi

31-501

Szpital Uniwersytecki w Krakowie, Krakow

All Listed Sponsors
lead

CENTOGENE GmbH Rostock

INDUSTRY

NCT03029728 - Biomarker for Hereditary AngioEdema Disease | Biotech Hunter | Biotech Hunter